ZYD Product Catalog Final 102219 - Zydususa

46
PRODUCT CATALOG www.zydususa.com UPDATED AS OF OCTOBER 2019

Transcript of ZYD Product Catalog Final 102219 - Zydususa

Page 1: ZYD Product Catalog Final 102219 - Zydususa

P R O D U C TC A T A L O G

www.zydususa.com

U P D AT E D A S O F O C T O B E R 2 0 1 9

Page 2: ZYD Product Catalog Final 102219 - Zydususa
Page 3: ZYD Product Catalog Final 102219 - Zydususa

TABLE OFCONTENTS

1 | GENERIC PRODUCTS .................................................................................................... 2

2 | THERAPEUTIC EQUIVALENCE CODES .......................... 31

3 | THERAPEUTIC CATEGORIES .................................................................. 32

4 | BRAND TO GENERIC GUIDE ................................................................... 36

5 | ORDERING INFORMATION ....................................................................... 40

6 | RETURN GOODS POLICY ............................................................................... 41

7 | CONTACT INFORMATION ........................................................................... 43

1Latex Free indicates that the container closure is not made with natural rubber latex.

TEMPERATURE CONTROLLEDSee Prescribing Information for any storage requirements on Temperature Controlled products

PRESERVATIVE FREEProduct does not contain any preservatives

LATEX FREE1

Container closure is not made with natural rubber latex

Page 4: ZYD Product Catalog Final 102219 - Zydususa

Acamprosate Calcium Delayed-Release Tablets | AB-Rated to Campral® Delayed-Release Tablets

68382-0569-28 333mg 180 24 Round; White to Off-White; 569

Acyclovir Ointment, USP | AB-Rated to Zovirax® Ointment

68382-0992-01 0.50% 15gm 48 White to Off-White

68382-0992-04 0.50% 30gm 48 White to Off-White

Acyclovir Tablets, USP | AB-Rated to Zovirax® Tablets

68382-0791-01 400mg 100 24 Round; White to Off-White; 791

68382-0791-05 400mg 500 12 Round; White to Off-White; 791

68382-0792-01 800mg 100 24 Oval; White to Off-White; 792

68382-0792-05 800mg 500 12 Oval; White to Off-White; 792

Albendazole Tablets, USP | AB-Rated to Albenza® Tablets

70710-1021-08 200mg 2 24 Round; White to Off-White; 1021

Allopurinol Tablets, USP | AB-Rated to Zyloprim® Tablets

70710-1209-01 100mg 100 24 Round; White to Off-White; 1/209 Breakline

70710-1209-00 100mg 1000 12 Round; White to Off-White; 1/209 Breakline

70710-1210-01 300mg 100 24 Round; Light Peach to Peach; 12/10 Breakline

70710-1210-05 300mg 500 12 Round; Light Peach to Peach; 12/10 Breakline

Amantadine HCl Capsules, USP | AB-Rated to Symmetrel® Capsules

68382-0512-01 100mg 100 24 Capsule; Red/Red; 652

68382-0512-05 100mg 500 12 Capsule; Red/Red; 652

Ambrisentan Tablets | AB-Rated to Letairis® Tablets

70710-1179-03 5mg 30 24 Round; Pink; 1179

70710-1180-03 10mg 30 24 Oval; White to Off-White; 1180

z y d u s u s a . c o m

2 | G E N E R I C P R O D U C T S

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

Page 5: ZYD Product Catalog Final 102219 - Zydususa

Amiodarone HCl Tablets | AB-Rated to Cordarone® Tablets

68382-0227-14 200mg 60 24 Round; White to Off-White; Bisect, ZE 65

68382-0227-05 200mg 500 12 Round; White to Off-White; Bisect, ZE 65

Amitriptyline HCl Tablets, USP | AB-Rated to Elavil® Tablets

70710-1225-00 10mg 1000 12 Round; White to Off-White; ZA/1

70710-1225-01 10mg 100 24 Round; White to Off-White; ZA/1

70710-1226-00 25mg 1000 12 Round; Light Green; ZA/2

70710-1226-01 25mg 100 24 Round; Light Green; ZA/2

70710-1227-00 50mg 1000 12 Round; Brown; ZA/3

70710-1227-01 50mg 100 24 Round; Brown; ZA/3

70710-1228-01 75mg 100 24 Round; Light Blue; 12 28

70710-1229-01 100mg 100 24 Round; Orange; 12 29

70710-1230-01 150mg 100 24 ModifiedCapsule-Shaped; Cream to Beige; 1230

Amlodipine Besylate Tablets, USP | AB-Rated to Norvasc® Tablets

68382-0121-16 2.5mg 90 24 Round; White to Off-White; Z/7

68382-0121-05 2.5mg 500 12 Round; White to Off-White; Z/7

68382-0122-16 5mg 90 24 Round; White to Off-White; Z3

68382-0122-05 5mg 500 12 Round; White to Off-White; Z3

68382-0123-16 10mg 90 24 Round; White to Off-White; Z5

68382-0123-05 10mg 500 12 Round; White to Off-White; Z5

Anastrozole Tablets, USP | AB-Rated to Arimidex® Tablets

68382-0209-06 1mg 30 24 Round; White; A7

Arsenic Trioxide Injection | AP-Rated to Trisenox® Injection

68382-0997-10 1mg/mL 10mL/vial x 10 12 Single-Dose Vial

70710-1610-01 2mg/mL 10mL/vial x 10 12 Single-Dose Vial

z y d u s u s a . c o m

3G E N E R I C P R O D U C T S |

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

Page 6: ZYD Product Catalog Final 102219 - Zydususa

Atenolol Tablets, USP | AB-Rated to Tenormin® Tablets

68382-0022-01 25mg 100 24 Round; White to Off-White; Z/65

68382-0022-10 25mg 1000 12 Round; White to Off-White; Z/65

68382-0023-01 50mg 100 24 Round; White to Off-White; Bisect, Z 66

68382-0023-10 50mg 1000 12 Round; White to Off-White; Bisect, Z 66

68382-0024-01 100mg 100 24 Round; White to Off-White; Z 67

68382-0024-10 100mg 1000 12 Round; White to Off-White; Z 67

Atenolol/Chlorthalidone Tablets, USP | AB-Rated to Tenoretic® Tablets

70710-1167-01 50mg/25mg 100 24 Round; White to Off-White; "11"&"67"

70710-1168-01 100mg/25mg 100 24 Round; White to Off-White; "11"&"68"

Atorvastatin Calcium Tablets, USP | AB-Rated to Lipitor® Tablets

68382-0249-16 10mg 90 24 Oval; White to Off-White; 249

68382-0249-10 10mg 1000 12 Oval; White to Off-White; 249

68382-0250-16 20mg 90 24 Oval; White to Off-White; 250

68382-0250-10 20mg 1000 12 Oval; White to Off-White; 250

68382-0251-16 40mg 90 24 Oval; White to Off-White; 251

68382-0251-10 40mg 1000 12 Oval; White to Off-White; 251

68382-0252-16 80mg 90 24 Oval; White to Off-White; 252

68382-0252-10 80mg 1000 12 Oval; White to Off-White; 252

z y d u s u s a . c o m

4 | G E N E R I C P R O D U C T S

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

Page 7: ZYD Product Catalog Final 102219 - Zydususa

Azathioprine Tablets, USP | AB-Rated to Imuran® Tablets

68382-0003-01 50mg 100 24 Round; Yellow, Bisect; ZC 59

68382-0003-05 50mg 500 12 Round; Yellow, Bisect; ZC 59

Azithromycin Oral Suspension, USP | AB-Rated to Zithromax® Oral Suspension

70710-1457-01 100mg/5mL 15mL 24 WhitetoLightPink;Cherryflavor

70710-1458-02 200mg/5mL 15mL 24 WhitetoLightPink;Cherryflavor

70710-1459-02 200mg/5mL 22.5mL 24 WhitetoLightPink;Cherryflavor

70710-1460-02 200mg/5mL 30mL 24 WhitetoLightPink;Cherryflavor

Baclofen Tablets, USP | AB-Rated to Lioresal® Tablets

70710-1285-01 10mg 100 24 Round; White to Off-White; 1285

70710-1285-05 10mg 500 12 Round; White to Off-White; 1285

70710-1285-00 10mg 1000 12 Round; White to Off-White; 1285

70710-1286-01 20mg 100 24 Round; White to Off-White; 1286

70710-1286-05 20mg 500 12 Round; White to Off-White; 1286

70710-1286-00 20mg 1000 12 Round; White to Off-White; 1286

Benzonatate Capsules, USP | AA-Rated to Tessalon® Perles

68382-0247-01 100mg 100 24 Round; Light Yellow; Z

68382-0247-05 100mg 500 12 Round; Light Yellow; Z

Benztropine Mesylate Injection, USP | AP-Rated to Cogentin® Injection

68382-0860-10 2mg/mL 2mL/vial x 5 96 Single-Dose Vial

z y d u s u s a . c o m

5G E N E R I C P R O D U C T S |

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

Page 8: ZYD Product Catalog Final 102219 - Zydususa

z y d u s u s a . c o m

6 | G E N E R I C P R O D U C T S

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

Betamethasone Dipropionate Cream, USP | AB-Rated to Diprosone® Cream

70710-1233-01 0.05% 15gm 48 White to Off-White

70710-1233-04 0.05% 45gm 48 White to Off-White

Bosentan Tablets | AB-Rated to Tracleer® Tablets

68382-0446-14 62.5mg 60 24 Round; Peach to Light Pink; 446

68382-0447-14 125mg 60 24 Oval; Peach to Light Pink; 447

Bromocriptine Mesylate Capsules, USP | AB-Rated to Parlodel® Capsules

68382-0110-06 5mg 30 24 Capsule; Tan/White; ZA 17/5 mg

Budesonide Capsules (Enteric Coated) | AB-Rated to Entocort® EC Capsules

68382-0720-01 3mg 100 24 Capsule; Light Orange Opaque/ White Opaque; 720

Bumetanide Tablets, USP | AB-Rated to Bumex® Tablets

68382-0525-01 0.5mg 100 24 Round; Light Green; “5”&”25”

68382-0526-01 1mg 100 24 Round; Light Yellow; “5”&”26”

68382-0527-01 2mg 100 24 Round; Light Orange; “5”&”27” Bupr

Bupropion HCl Extended-Release Tablets, USP | AB-Rated to Wellbutrin® XL Extended-Release Tablets

68382-0353-06 150mg 30 24 Round; Creamy White to Pale Yellow; 353

68382-0353-16 150mg 90 24 Round; Creamy White to Pale Yellow; 353

68382-0353-05 150mg 500 12 Round; Creamy White to Pale Yellow; 353

Page 9: ZYD Product Catalog Final 102219 - Zydususa

Buspirone HCl Tablets, USP | AB-Rated to BuSpar® Tablets

68382-0180-01 5mg 100 24 Capsule-Shaped; White to Off-White; Bisect, ZE 36

68382-0180-05 5mg 500 12 Capsule-Shaped; White to Off-White; Bisect, ZE 36

68382-0181-01 10mg 100 24 Capsule-Shaped; White to Off-White; Bisect, ZE 37

68382-0181-05 10mg 500 12 Capsule-Shaped; White to Off-White; Bisect, ZE 37

68382-0182-01 15mg 100 24 Capsule-Shaped; White to Off-White; Bisect, ZE 38/ Trisect, 5 5 5

68382-0182-05 15mg 500 12 Capsule-Shaped; White to Off-White; Bisect, ZE 38/ Trisect, 5 5 5

68382-0183-14 30mg 60 24 Capsule-Shaped; White to Off-White; Bisect, ZE 38/ Trisect, 10 10 10

68382-0183-05 30mg 500 12 Capsule-Shaped; White to Off-White; Bisect, ZE 38/ Trisect, 10 10 10

Carvedilol Tablets, USP | AB-Rated to Coreg® Tablets

68382-0092-01 3.125mg 100 24 Round; White to Off-White; Z/1

68382-0092-05 3.125mg 500 12 Round; White to Off-White; Z/1

68382-0093-01 6.25mg 100 24 Round; White to Off-White; ZC40

68382-0093-05 6.25mg 500 12 Round; White to Off-White; ZC40

68382-0094-01 12.5mg 100 24 Round; White to Off-White; ZC41

68382-0094-05 12.5mg 500 12 Round; White to Off-White; ZC41

68382-0095-01 25mg 100 24 Round; White to Off-White; ZC42

68382-0095-05 25mg 500 12 Round; White to Off-White; ZC42

z y d u s u s a . c o m

7G E N E R I C P R O D U C T S |

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

Carmustine for Injection, USP | AP-Rated to BiCNU® Injection

70710-1525-09 100mg Kit includes one 24 Single-Dose Vial 30mL vial of of Carmustine for Carmustine for Injection, USP and Injection, USP Single-Dose Vial and one 3mL vial of Diluent of diluent

Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

Page 10: ZYD Product Catalog Final 102219 - Zydususa

8 | G E N E R I C P R O D U C T S

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

Cholestyramine Light Powder for Suspension, USP | AB-Rated to Questran® Light Powder for Suspension

68382-0529-42 4gm 231gm 12 White; Vanilla-Orange Flavor

68382-0529-60 4gm Carton of 12 White; Vanilla-Orange Flavor 60 Pouches

Cholestyramine Powder for Suspension, USP | AB-Rated to Questran® Powder for Suspension

68382-0528-42 4gm 378gm 12 Light Yellow; Vanilla-Orange Flavor

68382-0528-60 4gm Carton of 12 Light Yellow; Vanilla-Orange Flavor 60 Pouches

Clobazam Tablets | AB-RatedtoOnfi®Tablets

70710-1325-01 10mg 100 24 Capsule-Shaped; White to Off-White;13/25

70710-1326-01 20mg 100 24 Capsule-Shaped; White to Off-White;13/26

Clobetasol Propionate Cream, USP | AB1-Rated to Temovate® Cream

70710-1456-01 0.05% 15gm 48 White to Off-White

70710-1456-02 0.05% 30gm 48 White to Off-White

70710-1456-04 0.05% 45gm 48 White to Off-White

70710-1456-03 0.05% 60gm 48 White to Off-White

Clobetasol Propionate Ointment, USP | AB-Rated to Temovate® Ointment

70710-1401-01 0.05% 15gm 48 Translucent

70710-1401-02 0.05% 30gm 48 Translucent

70710-1401-04 0.05% 45gm 48 Translucent

70710-1401-03 0.05% 60gm 48 Translucent

Clobetasol Propionate Spray | AT-Rated to Clobex® Spray

68382-0998-01 0.05% 59mL 24 Clear; Colorless

68382-0998-02 0.05% 125mL 24 Clear; Colorless

z y d u s u s a . c o m

Page 11: ZYD Product Catalog Final 102219 - Zydususa

Clomipramine HCl Capsules, USP | AB-Rated to Anafranil® Capsules

70710-1065-03 25mg 30 24 Capsule; Pink/Light Pink; 1065

70710-1065-01 25mg 100 24 Capsule; Pink/Light Pink; 1065

70710-1066-03 50mg 30 24 Capsule; Yellow/Light Pink; 1066

70710-1066-01 50mg 100 24 Capsule; Yellow/Light Pink; 1066

70710-1067-03 75mg 30 24 Capsule; Dark Pink/Light Pink; 1067

70710-1067-01 75mg 100 24 Capsule; Dark Pink/Light Pink; 1067

Cyproheptadine HCl Tablets, USP | AB-Rated to Periactin® Tablets

70710-1110-01 4mg 100 24 Round; White; 11 10/Bisect

70710-1110-00 4mg 1000 12 Round; White; 11 10/Bisect

Desmopressin Acetate Nasal Spray | AB-Rated to DDAVP® Nasal Spray

68382-0384-01 0.01% 5mL 48

Desoximetasone Ointment, USP | AB-Rated to Topicort® Ointment

68382-0889-03 0.25% 15gm 48 Off-White

68382-0889-01 0.25% 60gm 48 Off-White

68382-0889-02 0.25% 100gm 36 Off-White

9G E N E R I C P R O D U C T S |

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

z y d u s u s a . c o m

Page 12: ZYD Product Catalog Final 102219 - Zydususa

| G E N E R I C P R O D U C T S

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

z y d u s u s a . c o m

Dextroamphetamine Saccharate, Amphetamine Aspartate, AB-Rated toDextroamphetamine Sulfate and Amphetamine Sulfate Tablets | Adderall® Tablets

68382-0950-01 5mg 100 24 Oval; Blue; “N”&”950”

68382-0951-01 7.5mg 100 24 Round; Blue; “N”&”951”

68382-0952-01 10mg 100 24 Oval; Blue; “N”&”952”

68382-0953-01 12.5mg 100 24 Oval; Peach; “N”&”953”

68382-0954-01 15mg 100 24 Round; Peach; “N”&”954”

68382-0955-01 20mg 100 24 Oval; Peach; “N”&”955”

68382-0956-01 30mg 100 24 Oval; Peach; “N”&”956”

Diltiazem HCl Extended-Release Capsules, USP | AB-Rated to Cardizem® CD Extended-Release Capsules

68382-0595-16 120mg 90 24 Capsule; Opaque Light Green/ Opaque White; 595

68382-0595-05 120mg 500 12 Capsule; Opaque Light Green/ Opaque White; 595

68382-0596-16 180mg 90 24 Capsule; Opaque Light Blue/ Opaque Grey; 596

68382-0596-05 180mg 500 12 Capsule; Opaque Light Blue/ Opaque Grey; 596

68382-0597-16 240mg 90 24 Capsule; Opaque Light Blue/ Opaque White; 597

68382-0597-05 240mg 500 12 Capsule; Opaque Light Blue/ Opaque White; 597

68382-0598-16 300mg 90 24 Capsule; Opaque Light Green/ Opaque Grey; 598

68382-0598-05 300mg 500 12 Capsule; Opaque Light Green/ Opaque Grey; 598

68382-0599-16 360mg 90 24 Capsule; Opaque Grey/ Opaque White; 599

10

Page 13: ZYD Product Catalog Final 102219 - Zydususa

G E N E R I C P R O D U C T S |

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

z y d u s u s a . c o m

Divalproex Sodium Capsules (Sprinkle), USP | AB-Rated to Depakote® Sprinkle Capsules

68382-0106-01 125mg 100 24 Capsule; Blue/White; ZA66/125mg

68382-0106-10 125mg 1000 12 Capsule; Blue/White; ZA66/125mg

Doxazosin Tablets, USP | AB-Rated to Cardura® Tablets

68382-0783-01 1mg 100 24 Round; White to Off-White; 783

68382-0783-10 1mg 1000 12 Round; White to Off-White; 783

68382-0784-01 2mg 100 24 Round; Light Pink to Pink; 784

68382-0784-10 2mg 1000 12 Round; Light Pink to Pink; 784

68382-0785-01 4mg 100 24 Capsule-Shaped; Light Pink to Pink; 785

68382-0785-10 4mg 1000 12 Capsule-Shaped; Light Pink to Pink; 785

68382-0786-01 8mg 100 24 Round; Light Purple to Purple; 786

68382-0786-10 8mg 1000 12 Round; Light Purple to Purple; 786

11

Page 14: ZYD Product Catalog Final 102219 - Zydususa

12 | G E N E R I C P R O D U C T S

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

z y d u s u s a . c o m

Doxycycline for Injection, USP | AP-Rated to Doxy 100® Injection

68382-0910-10 100mg 10mL vial x 10 24 Single-Dose Vial

Doxycycline Monohydrate Capsules, USP | AB-Rated to Monodox® Capsules

68382-0782-01 50mg 100 24 Capsule; Opaque Yellow/Opaque White; 782/Plain

68382-0707-18 100mg 50 24 Capsule; Opaque Yellow/Opaque Orange; 707/Plain

Doxycycline Tablets, USP | AB-Rated to Adoxa® Tablets

70710-1121-01 50mg 100 24 Round; Off-White/Pale Yellow; 1121

70710-1122-01 75mg 100 24 Round; Light Orange/Creamish Orange; 1122

70710-1123-07 100mg 50 24 Round; Lemon Yellow/Buff; 1123

70710-1124-03 150mg 30 24 Round; Dark Orange/Creamish Orange; 1124

Duloxetine Delayed-Release Capsules, USP | AB-Rated to Cymbalta® Delayed-Release Capsules

68382-0385-14 20mg 60 24 Capsule; Green/White; 241/20 mg

68382-0386-06 30mg 30 24 Capsule; Blue/Green; 242/30 mg

68382-0387-06 60mg 30 24 Capsule; Blue/White; 243/60 mg

Dutasteride/Tamsulosin HCl Capsules | AB-rated to Jalyn® Capsules

68382-0640-06 0.5mg/0.4mg 30 24 Capsule; Opaque Yellow/Opaque White; 640

68382-0640-16 0.5mg/0.4mg 90 24 Capsule; Opaque Yellow/Opaque White; 640

Eletriptan HBr Tablets | AB-Rated to Relpax® Tablets

68382-0922-86 20mg 6 72 Round; Orange to Mottled Orange; 922

68382-0923-86 40mg 6 72 Round; Brown; 923

Page 15: ZYD Product Catalog Final 102219 - Zydususa

13G E N E R I C P R O D U C T S |

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

z y d u s u s a . c o m

Entecavir Tablets, USP | AB-Rated to Baraclude® Tablets

68382-0920-06 0.5mg 30 24 Round; White to Off-White; 920

68382-0921-06 1mg 30 24 Round; Light Pink to Pink; 921

Esomeprazole Magnesium Delayed-Release Capsules, USP | AB-Rated to Nexium® Delayed-Release Capsules

68382-0441-06 20mg 30 24 Capsule; Blue Opaque/White Opaque; 441/20mg

68382-0441-16 20mg 90 24 Capsule; Blue Opaque/White Opaque; 441/20mg

68382-0441-10 20mg 1000 12 Capsule; Blue Opaque/White Opaque; 441/20mg

68382-0442-06 40mg 30 24 Capsule; Blue Opaque/White Opaque; 442/40mg

68382-0442-16 40mg 90 24 Capsule; Blue Opaque/White Opaque; 442/40mg

68382-0442-10 40mg 1000 12 Capsule; Blue Opaque/White Opaque; 442/40mg

Ethacrynate Sodium for Injection, USP | AP-Rated to Edecrin® Injection

68382-0246-01 50mg 50mL vial 24 Single-Dose Vial

Etodolac Extended-Release Tablets, USP | AB-Rated to Lodine XL® Extended-Release Tablets

68382-0271-14 400mg 60 24 Oval; Orange; 271

68382-0271-01 400mg 100 24 Oval; Orange; 271

68382-0272-14 500mg 60 24 Oval; Grey; 272

68382-0272-01 500mg 100 24 Oval; Grey; 272

68382-0273-14 600mg 60 24 Oval; Blue; 273

68382-0273-01 600mg 100 24 Oval; Blue; 273

Page 16: ZYD Product Catalog Final 102219 - Zydususa

14 | G E N E R I C P R O D U C T S

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

Exemestane Tablets | AB-Rated to Aromasin® Tablets

68382-0383-06 25mg 30 24 Round; White to Off-White; 383

Ezetimibe Tablets, USP | AB-Rated to Zetia® Tablets

68382-0773-06 10mg 30 24 Capsule-Shaped; White to Off-White; 773

68382-0773-16 10mg 90 24 Capsule-Shaped; White to Off-White; 773

68382-0773-05 10mg 500 12 Capsule-Shaped; White to Off-White; 773

Fenofi brate Tablets | Same as TriCor® Tablets

68382-0269-16 48mg 90 24 Oval; Yellow; FI

68382-0270-16 145mg 90 24 Oval; White; FO

Fenofi bric Acid Delayed-Release Capsules | Same as Trilipix® Delayed-Release Capsules

68382-0232-16 45mg 90 24 Capsule; Reddish-Brown/Yellow; 45

68382-0233-16 135mg 90 24 Capsule; Blue/Yellow; 135

Fluconazole Tablets, USP | AB-RatedtoDiflucan®Tablets

70710-1137-03 50mg 30 24 Oval; Light Pink to Pink; 1137

70710-1138-03 100mg 30 24 Oval; Light Pink to Pink; 1138

70710-1138-01 100mg 100 24 Oval; Light Pink to Pink; 1138

70710-1139-08 150mg 12 24 Oval; Light Pink to Pink; 1139

70710-1140-03 200mg 30 24 Oval; Light Pink to Pink; 1140

70710-1140-01 200mg 100 24 Oval; Light Pink to Pink; 1140

z y d u s u s a . c o m

Page 17: ZYD Product Catalog Final 102219 - Zydususa

Fomepizole Injection | AP-Rated to Antizol® Injection

70710-1478-01 1.5gm/1.5mL 1.5mL/vial 24 Single-Use Vial

Gabapentin Tablets, USP | AB-Rated to Neurontin® Tablets

68382-0204-01 600mg 100 24 Oval; White to Off-White; ZE72 Bisect/Bisect

68382-0204-05 600mg 500 12 Oval; White to Off-White; ZE72 Bisect/Bisect

68382-0205-01 800mg 100 24 Oval; White to Off-White; ZE71 Bisect/Bisect

68382-0205-05 800mg 500 12 Oval; White to Off-White; ZE71 Bisect/Bisect

Glipizide Extended-Release Tablets | AB-Rated to Glucotrol® XL Extended-Release Tablets

68382-0335-06 2.5mg 30 24 Round; Yellow; 2

68382-0336-01 5mg 100 24 Round; Orange; 3 68382-0336-05 5mg 500 12 Round; Orange; 3

68382-0337-01 10mg 100 24 Round; White; 4 68382-0337-05 10mg 500 12 Round; White; 4

Glipizide/Metformin HCl Tablets, USP | AB-Rated to Metaglip® Tablets

68382-0184-01 2.5/250mg 100 24 ModifiedCapsule-Shaped;Pink;ZE68

68382-0185-01 2.5/500mg 100 24 ModifiedCapsule-Shaped;White;ZE67

68382-0186-01 5/500mg 100 24 ModifiedCapsule-Shaped;Pink;ZE66

15G E N E R I C P R O D U C T S |

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

z y d u s u s a . c o m

Page 18: ZYD Product Catalog Final 102219 - Zydususa

Haloperidol Tablets, USP | AB-Rated to Haloperidol Tablets, USP

68382-0079-01 5mg 100 24 Capsule-Shaped; Green; Partial Bisect, ZC 07 68382-0079-10 5mg 1000 12 Capsule-Shaped; Green; Partial Bisect, ZC 07

68382-0080-01 10mg 100 24 Capsule-Shaped; Light Green; Partial Bisect, ZC 08

68382-0081-01 20mg 100 24 Capsule-Shaped; Coral; Bisect, ZC 09

Hydroxychloroquine Sulfate Tablets, USP | AB-Rated to Plaquenil® Tablets

68382-0096-01 200mg 100 24 Capsule-Shaped; White to Off-White; ZC38

68382-0096-05 200mg 500 12 Capsule-Shaped; White to Off-White; ZC38

Indomethacin for Injection, USP | AP-Rated to Indocin® Injection

68382-0470-01 1mg 3mL vial 40 Single-Dose Vial

Isosorbide Mononitrate Extended-Release Tablets | AB-Rated to Imdur® Extended-Release Tablets

68382-0650-01 30mg 100 24 Oval; Reddish Pink; "N" Bisect "30"/ Bisect 68382-0650-05 30mg 500 12 Oval; Reddish Pink; “N” Bisect “30”/ Bisect

68382-0651-01 60mg 100 24 Oval; Yellow; ”N” Bisect “60”/ Bisect 68382-0651-05 60mg 500 12 Oval; Yellow; ”N” Bisect “60”/ Bisect

68382-0652-01 120mg 100 24 Oval; White, N120

| G E N E R I C P R O D U C T S

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

16Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

z y d u s u s a . c o m

Page 19: ZYD Product Catalog Final 102219 - Zydususa

Labetalol HCl Tablets, USP | AB-Rated to Normodyne® Tablets

68382-0798-01 100mg 100 24 Round; Yellow; 798, Score Line

68382-0798-05 100mg 500 12 Round; Yellow; 798, Score Line

68382-0799-01 200mg 100 24 Round; White to Off-White; 799, Score Line

68382-0799-05 200mg 500 12 Round; White to Off-White; 799, Score Line

68382-0800-01 300mg 100 24 Round; Green; 800

68382-0800-05 300mg 500 12 Round; Green; 800

Lamotrigine Tablets, USP | AB-Rated to Lamictal® Tablets

68382-0006-01 25mg 100 24 Round; White to Off-White; Bisect, ZC 79

68382-0006-10 25mg 1000 12 Round; White to Off-White; Bisect, ZC 79

68382-0008-01 100mg 100 24 Round; White to Off-White; Bisect, ZC 80

68382-0008-10 100mg 1000 12 Round; White to Off-White; Bisect, ZC 80

68382-0009-14 150mg 60 24 Round; White to Off-White; Bisect, ZC 81

68382-0009-05 150mg 500 12 Round; White to Off-White; Bisect, ZC 81

68382-0010-14 200mg 60 24 Round; White to Off-White; Bisect, ZC 82

68382-0010-05 200mg 500 12 Round; White to Off-White; Bisect, ZC 82

Lansoprazole Delayed-Release Capsules, USP | AB-Rated to Prevacid® Delayed-Release Capsules

68382-0543-06 15mg 30 24 Capsule; Opaque Pink/Opaque White; ZA-50/15mg

68382-0543-10 15mg 1000 12 Capsule; Opaque Pink/Opaque White; ZA-50/15mg

68382-0544-06 30mg 30 24 Capsule; Opaque Pink/Opaque White; ZA-51/30mg

68382-0544-16 30mg 90 24 Capsule; Opaque Pink/Opaque White; ZA-51/30mg

68382-0544-01 30mg 100 24 Capsule; Opaque Pink/Opaque White; ZA-51/30mg

68382-0544-10 30mg 1000 12 Capsule; Opaque Pink/Opaque White; ZA-51/30mg

G E N E R I C P R O D U C T S |

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

17Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

z y d u s u s a . c o m

Page 20: ZYD Product Catalog Final 102219 - Zydususa

| G E N E R I C P R O D U C T S

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

18Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

Lansoprazole Delayed-Release | AB-Rated to Prevacid® SoluTab® Delayed-ReleaseOrally-Disintegrating Tablets Orally-Disintegrating Tablets

68382-0771-77 15mg 100 12 Round; White to Off-White; 771

68382-0772-77 30mg 100 12 Round; White to Off-White; 772

Lefl unomide Tablets, USP | AB-Rated to Arava® Tablets

70710-1157-03 10mg 30 24 Round; White to Off-White; "57"&"11"

70710-1158-03 20mg 30 24 Triangular; White to Off-White; "58"&"11"

Losartan Potassium Tablets, USP | AB-Rated to Cozaar® Tablets

68382-0135-06 25mg 30 24 Capsule-Shaped; White to Off-White; Z/2 68382-0135-16 25mg 90 24 Capsule-Shaped; White to Off-White; Z/2 68382-0135-10 25mg 1000 12 Capsule-Shaped; White to Off-White; Z/2

68382-0136-06 50mg 30 24 Capsule-Shaped; White to Off-White; Z16/Breakline 68382-0136-16 50mg 90 24 Capsule-Shaped; White to Off-White; Z16/Breakline 68382-0136-10 50mg 1000 12 Capsule-Shaped; White to Off-White; Z16/Breakline

68382-0137-06 100mg 30 24 Capsule-Shaped; White to Off-White; Z18 68382-0137-16 100mg 90 24 Capsule-Shaped; White to Off-White; Z18 68382-0137-10 100mg 1000 12 Capsule-Shaped; White to Off-White; Z18

Meloxicam Tablets, USP | AB-Rated to Mobic® Tablets

68382-0050-01 7.5mg 100 24 Round; Yellow; ZC 25

68382-0050-05 7.5mg 500 12 Round; Yellow; ZC 25

68382-0051-01 15mg 100 24 Round; Yellow; ZC 26

68382-0051-05 15mg 500 12 Round; Yellow; ZC 26

Mesalamine Delayed-Release Tablets, USP | Compare to Asacol® HD Delayed-Release Tablets

68382-0435-28 800mg 180 24 Capsule-Shaped; Red-Brown; 435

Mesalamine Delayed-Release Tablets | AB-Rated to Lialda® Delayed-Release Tablets

68382-0711-19 1.2mg 120 24 Oval-Shaped; Pale Red-Brown; 711

z y d u s u s a . c o m

Page 21: ZYD Product Catalog Final 102219 - Zydususa

Metformin HCl Tablets, USP | AB-Rated to Glucophage® Tablets

68382-0758-01 500mg 100 24 Round; White to Off-White; 70/Z

68382-0758-05 500mg 500 12 Round; White to Off-White; 70/Z

68382-0758-10 500mg 1000 12 Round; White to Off-White; 70/Z

68382-0759-01 850mg 100 24 Oval; White to Off-White; 69/Z

68382-0759-05 850mg 500 12 Oval; White to Off-White; 69/Z

68382-0759-10 850mg 1000 12 Oval; White to Off-White; 69/Z

68382-0760-01 1000mg 100 24 Oval; White to Off-White; Bisect, Z 71

68382-0760-05 1000mg 500 12 Oval; White to Off-White; Bisect, Z 71

68382-0760-10 1000mg 1000 12 Oval; White to Off-White; Bisect, Z 71

Methotrexate Tablets, USP | AB-Rated to Rheumatrex® Tablets

68382-0775-01 2.5mg 100 24 Round; Yellow; L2/Bisect

Methylprednisolone Tablets, USP | AB-Rated to Medrol® Tablets

68382-0916-34 4mg 21 36 Oval; White to Off-White; 916

68382-0916-01 4mg 100 24 Oval; White to Off-White; 916

68382-0917-11 8mg 25 24 Oval; White to Off-White; 917

68382-0918-18 16mg 50 24 Oval; White to Off-White; 918

68382-0919-11 32mg 25 24 Oval; White to Off-White; 919

Metoprolol Succinate Extended-Release Tablets, USP | AB-Rated to Toprol-XL® Extended-Release Tablets

68382-0564-01 25mg 100 24 Oval; White to Off-White; 564

68382-0564-10 25mg 1000 12 Oval; White to Off-White; 564

68382-0565-01 50mg 100 24 Round; White to Off-White; 565

68382-0565-10 50mg 1000 12 Round; White to Off-White; 565

68382-0566-01 100mg 100 24 Round; White to Off-White; 566

68382-0566-10 100mg 1000 12 Round; White to Off-White; 566

68382-0567-01 200mg 100 24 Oval; White to Off-White; “5”&“67”

68382-0567-05 200mg 500 12 Oval; White to Off-White; “5”&“67”

G E N E R I C P R O D U C T S |

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

19Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

z y d u s u s a . c o m

Page 22: ZYD Product Catalog Final 102219 - Zydususa

Minocycline HCl Capsules, USP | AB-Rated to Minocin® Capsules

68382-0316-01 50mg 100 60 Capsule; Pink/Pink; = /316

68382-0317-01 75mg 100 60 Capsule; White/Light Gray; = /317

68382-0318-01 100mg 100 72 Capsule; Maroon/Pink; = /318

Nadolol Tablets, USP | AB-Rated to Corgard® Tablets

68382-0732-01 20mg 100 24 Round; White to Off-White; Bisect, N 20

68382-0733-01 40mg 100 24 Round; White to Off-White; Bisect, N 40

68382-0734-01 80mg 100 24 Round; White to Off-White; Bisect, N 80

Nateglinide Tablets, USP | AB-Rated to Starlix® Tablets

68382-0721-16 60mg 90 24 Round; White to Off-White; 721

68382-0722-16 120mg 90 24 Oval; Light-Orange to Orange; 722

Nitrofurantoin Capsules, USP (Macrocrystals) | AB-Rated to Macrodantin® Capsules

68382-0559-01 50mg 100 24 Capsule; Blue/White; 559

68382-0560-01 100mg 100 24 Capsule; Blue/Blue; 560

Nitroglycerin Transdermal System | Same as Nitroglycerin Transdermal System (AB2 rating)

68382-0309-30 0.2mg/HR 30 24 7cm2; Transparent Outer Backing; Nitroglycerin 0.2mg/hr

68382-0310-30 0.4mg/HR 30 24 14cm2; Transparent Outer Backing; Nitroglycerin 0.4mg/hr

68382-0311-30 0.6mg/HR 30 24 21cm2; Transparent Outer Backing; Nitroglycerin 0.6mg/hr

| G E N E R I C P R O D U C T S

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

20Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

z y d u s u s a . c o m

Page 23: ZYD Product Catalog Final 102219 - Zydususa

Omeprazole Delayed-Release Capsules, USP | AB-Rated to Prilosec® Delayed-Release Capsules

68382-0411-01 10mg 100 24 Capsule; Amethyst Purple/White; ZA-09/10 mg

68382-0412-05 20mg 500 12 Capsule; Tan/White; ZA-10/20 mg

68382-0500-01 40mg 100 24 Capsule; Amethyst Purple/White; ZA-11/40 mg

68382-0500-10 40mg 1000 12 Capsule; Amethyst Purple/White; ZA-11/40 mg

Omeprazole/Sodium Bicarbonate Capsules | AB-Rated to Zegerid® Capsules

68382-0501-06 20/1100mg 30 24 Capsule; Opaque White/Opaque White; 501

68382-0502-06 40/1100mg 30 24 Capsule; Opaque White/Opaque White; 502

Oseltamivir Phosphate Capsules, USP | AB-RatedtoTamiflu®Capsules

70710-1008-02 30mg 10 24 Capsule; White/White; N/1008

70710-1009-02 45mg 10 24 Capsule; Light Blue Gray/Light Blue Gray; N/1009

70710-1010-02 75mg 10 24 Capsule; White/Light Blue Gray; N/1010

Oseltamivir Phosphate for Suspension | AB-RatedtoTamiflu®forSuspension

70710-1165-06 6mg/mL 60mL 24 White to Light Yellow; Tutti-Frutti Flavor

Oxybutynin Chloride Extended-Release Tablets | AB-Rated to Ditropan XL® Extended-Release Tablets

68382-0255-01 5mg 100 24 Round; White to Off-White; 255 68382-0255-05 5mg 500 12 Round; White to Off-White; 255

68382-0256-01 10mg 100 24 Round; White to Off-White; 256 68382-0256-05 10mg 500 12 Round; White to Off-White; 256

68382-0257-01 15mg 100 24 Round; White to Off-White; 257

G E N E R I C P R O D U C T S |

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

21Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

z y d u s u s a . c o m

Page 24: ZYD Product Catalog Final 102219 - Zydususa

Paricalcitol Capsules | Same as Zemplar® Capsules

68382-0330-06 1mcg 30 48 Oval; Gray; ZA

68382-0331-06 2mcg 30 48 Oval; Orange-Brown; ZF

Paroxetine Tablets, USP | Same as Paxil® Tablets

68382-0097-06 10mg 30 24 Round; White to Off-White; Bisect, ZC 15

68382-0097-16 10mg 90 24 Round; White to Off-White; Bisect, ZC 15

68382-0097-05 10mg 500 12 Round; White to Off-White; Bisect, ZC 15

68382-0097-10 10mg 1000 12 Round; White to Off-White; Bisect, ZC 15

68382-0098-06 20mg 30 24 Round; White to Off-White; Bisect, ZC 16

68382-0098-16 20mg 90 24 Round; White to Off-White; Bisect, ZC 16

68382-0098-01 20mg 100 24 Round; White to Off-White; Bisect, ZC 16

68382-0098-05 20mg 500 12 Round; White to Off-White; Bisect, ZC 16

68382-0098-10 20mg 1000 12 Round; White to Off-White; Bisect, ZC 16

68382-0099-06 30mg 30 24 Round; White to Off-White; ZC17

68382-0099-16 30mg 90 24 Round; White to Off-White; ZC17

68382-0099-05 30mg 500 12 Round; White to Off-White; ZC17

68382-0099-10 30mg 1000 12 Round; White to Off-White; ZC17

68382-0001-06 40mg 30 24 Round; White to Off-White; ZC18

68382-0001-16 40mg 90 24 Round; White to Off-White; ZC18

68382-0001-05 40mg 500 12 Round; White to Off-White; ZC18

| G E N E R I C P R O D U C T S

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

22Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

z y d u s u s a . c o m

Page 25: ZYD Product Catalog Final 102219 - Zydususa

Phytonadione Tablets, USP | AB-Rated to Mephyton® Tablets

70710-1014-01 5mg 100 24 Round; Light Yellow to Yellow; “10”&”14”

Potassium Chloride Extended-Release Tablets, USP | Same as K-Tab® Extended-Release Tablets

68382-0776-01 8mEq (600mg) 100 48 Round; Yellow; K-TAB

68382-0776-10 8mEq (600mg) 1000 12 Round; Yellow; K-TAB

68382-0320-01 10mEq (750mg) 100 48 Ovaloid; Yellow; "10"/K-TAB

68382-0320-10 10mEq (750mg) 1000 12 Ovaloid; Yellow; "10"/K-TAB

68382-0398-01 20mEq (1500mg) 100 48 Ovaloid; White; K-TAB

68382-0398-05 20mEq (1500mg) 500 12 Ovaloid; White; K-TAB

Potassium Citrate Extended-Release Tablets, USP | AB-Rated to Urocit-K® Extended-Release Tablets

68382-0536-01 5mEq 100 24 Round; Tan to Yellowish; 536

68382-0537-01 10mEq 100 24 Oval; Tan to Yellowish; 537

68382-0538-01 15mEq 100 24 Oblong; Tan to Yellowish; 538

Pravastatin Sodium Tablets, USP | AB-Rated to Pravachol® Tablets

68382-0070-16 10mg 90 24 Oval; White to Off-White; ZC46

68382-0070-05 10mg 500 12 Oval; White to Off-White; ZC46

68382-0071-16 20mg 90 24 Oval; White to Off-White; ZC45

68382-0071-05 20mg 500 12 Oval; White to Off-White; ZC45

68382-0072-16 40mg 90 24 Oval; White to Off-White; ZC44

68382-0072-05 40mg 500 12 Oval; White to Off-White; ZC44

68382-0073-16 80mg 90 24 Oval; White to Off-White; ZC43

68382-0073-05 80mg 500 12 Oval; White to Off-White; ZC43

G E N E R I C P R O D U C T S |

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

23Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

z y d u s u s a . c o m

Page 26: ZYD Product Catalog Final 102219 - Zydususa

Promethazine HCl Tablets, USP | AB-Rated to Phenergan® Tablets

68382-0040-01 12.5mg 100 24 Round; White to Off-White; Bisect, ZC 01

68382-0041-01 25mg 100 24 Round; White to Off-White; Quadrisect, Z C 0 2

68382-0041-10 25mg 1000 12 Round; White to Off-White; Quadrisect, Z C 0 2

68382-0042-01 50mg 100 24 Round; White to Off-White; ZC 03

Pyridostigmine Bromide Tablets, USP | AB-Rated to Mestinon® Tablets

68382-0659-06 60mg 30 24 Round; White to Off-White; Quadrisect/659

Ramelteon Tablets | AB-Rated to Rozerem® Tablets

70710-1344-03 8mg 30 24 Round; Light Yellow to Beige; 1344Ra 70710-1344-01 8mg 100 24 Round; Light Yellow to Beige; 1344

Ramipril Capsules, USP | AB-Rated to Altace® Capsules

68382-0144-06 1.25mg 30 24 Capsule; White Opaque/Yellow Opaque; ZA-43/1.25 mg

68382-0145-01 2.5mg 100 24 Capsule; White Opaque/Orange Opaque; ZA-44/2.5 mg

68382-0146-01 5mg 100 24 Capsule; White Opaque/Red Opaque; ZA-45/5 mg

68382-0147-01 10mg 100 24 Capsule; White Opaque/Blue Opaque; ZA-46/10 mg

Ranitidine Injection, USP | AP-Rated to Zantac® Injection

68382-0422-02 25mg/mL 2mL/vial x 10 1 Single-Dose Vial

68382-0423-06 25mg/mL 6mL/vial 12 Multi-Dose Vial

Ribavirin Capsules, USP | AB-Rated to Rebetol® Capsules

68382-0260-12 200mg 84 24 Capsule; White/White; ZA-12/200mg

| G E N E R I C P R O D U C T S

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

24Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

z y d u s u s a . c o m

Page 27: ZYD Product Catalog Final 102219 - Zydususa

Ribavirin for Inhalation Solution, USP | AP-Rated to Virazole® for Inhalation Solution

68382-0395-04 6gm 100mL vial x 4 12 Glass Vial

Ribavirin Tablets | AB-Rated to Copegus® Tablets

68382-0046-03 200mg 168 24 Round; Light Pink to Pink; ZC19

Risperidone Tablets, USP | AB-Rated to Risperdal® Tablets

68382-0112-14 0.25mg 60 24 Round; Dark Yellow; Z/4 68382-0112-05 0.25mg 500 12 Round; Dark Yellow; Z/4

68382-0113-14 0.5mg 60 24 Round; Red-Brown; Z/6 68382-0113-05 0.5mg 500 12 Round; Red-Brown; Z/6

68382-0114-14 1mg 60 24 Round; White to Off-White; ZC75 68382-0114-05 1mg 500 12 Round; White to Off-White; ZC75

68382-0115-14 2mg 60 24 Round; Orange; ZC76 68382-0115-05 2mg 500 12 Round; Orange; ZC76

68382-0116-14 3mg 60 24 Round; Yellow; ZC77 68382-0116-05 3mg 500 12 Round; Yellow; ZC77

68382-0117-14 4mg 60 24 Round; Green; ZC78 68382-0117-05 4mg 500 12 Round; Green; ZC78

Rivastigmine Transdermal Patch | AB-Rated to Exelon® Transdermal Patch

70710-1196-07 4.6mg/24hr 30 24 7.75cm2; Rivastigmine Transdermal System 4.6mg/24 hours

70710-1197-07 9.5mg/24hr 30 24 16cm2; Rivastigmine Transdermal System 4.6mg/24 hours

70710-1198-07 13.3mg/24hr 30 24 22.4cm2; Rivastigmine Transdermal System 4.6mg/24 hours

G E N E R I C P R O D U C T S |

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

25Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

z y d u s u s a . c o m

Page 28: ZYD Product Catalog Final 102219 - Zydususa

Sirolimus Tablets | AB-Rated to Rapamune® Tablets

68382-0520-01 0.5mg 100 24 Round; Yellow; 1

Sodium Phenylacetate/Sodium Benzoate Injection | AP-Rated to Ammonul® Injection

68382-0396-01 10%/10% 50mL/vial 24 Single-Dose Vial

Spironolactone Tablets, USP | AB-Rated to Aldactone® Tablets

68382-0660-01 25mg 100 24 Round; White to Off-White; 660

68382-0660-05 25mg 500 12 Round; White to Off-White; 660

68382-0660-10 25mg 1000 12 Round; White to Off-White; 660

68382-0661-01 50mg 100 24 Oval; White to Off-White; 661

68382-0661-05 50mg 500 12 Oval; White to Off-White; 661

68382-0662-01 100mg 100 24 Round; White to Off-White; 662

68382-0662-05 100mg 500 12 Round; White to Off-White; 662

Succinylcholine Chloride Injection, USP | AP-Rated to Quelicin® Injection

70710-1377-02 20mg/mL 10mL/vial x 25 12 Multi-Dose Vial

Tadalafi l Tablets, USP | AB-Rated to Cialis® Tablets

68382-0896-06 2.5mg 30 24 Oval; White; T1

68382-0897-06 5mg 30 24 Oval; Yellow; 897

68382-0898-06 10mg 30 24 Oval; White; 898

68382-0899-06 20mg 30 24 Oval; Yellow; 899

| G E N E R I C P R O D U C T S

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

26Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

AP-Rated to Ammonul® Injection

z y d u s u s a . c o m

Page 29: ZYD Product Catalog Final 102219 - Zydususa

G E N E R I C P R O D U C T S |

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

27Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

Tamoxifen Citrate Tablets, USP | AB-Rated to Nolvadex® Tablets

68382-0826-14 10mg 60 24 Round; White to Off-White; 826

68382-0827-06 20mg 30 24 Round; White to Off-White; 827

68382-0827-01 20mg 100 24 Round; White to Off-White; 827

Tamsulosin HCl Capsules, USP | AB-Rated to Flomax® Capsules

68382-0132-01 0.4mg 100 24 Capsule; Green/Peach; ZA-18/0.4 mg

68382-0132-10 0.4mg 1000 12 Capsule; Green/Peach; ZA-18/0.4 mg

Telmisartan Tablets, USP | AB-Rated to Micardis® Tablets

68382-0471-78 20mg 3x10 Blister Pack 36 Round; Mottled Light Brown to Mottled Brown; 471

68382-0472-78 40mg 3x10 Blister Pack 36 Oblong; Mottled Light Brown to Mottled Brown; 472

68382-0473-78 80mg 3x10 Blister Pack 36 Oblong; Mottled Light Brown to Mottled Brown; 473

Temozolomide Capsules | AB-Rated to Temodar® Capsules

68382-0751-96 5mg 5 24 Capsule; Green/White; 751

68382-0751-67 5mg 14 24 Capsule; Green/White; 751

68382-0752-96 20mg 5 24 Capsule; Yellow/White; 752

68382-0752-67 20mg 14 24 Capsule; Yellow/White; 752

68382-0753-96 100mg 5 24 Capsule; Pink/White; 753

68382-0753-67 100mg 14 24 Capsule; Pink/White; 753

68382-0754-96 140mg 5 24 Capsule; Blue/White; 754

68382-0754-67 140mg 14 24 Capsule; Blue/White; 754

68382-0755-96 180mg 5 24 Capsule; Orange/White; 755

68382-0755-67 180mg 14 24 Capsule; Orange/White; 755

68382-0756-96 250mg 5 24 Capsule; White/White; 756

z y d u s u s a . c o m

Page 30: ZYD Product Catalog Final 102219 - Zydususa

Tizanidine HCl Capsules | AB-RatedtoZanaflex®Capsules

70710-1111-08 2mg 150 24 Capsule; Light Blue/Light Blue; 1111

70710-1112-08 4mg 150 24 Capsule; Violet/White; 1112

70710-1113-08 6mg 150 24 Capsule; Violet/Violet; 1113

Topiramate Capsules (Sprinkle), USP | AB-Rated to Topamax® Sprinkle Capsules

68382-0004-14 15mg 60 24 Capsule; White Opaque/White Opaque; ZA63/15 mg

68382-0005-14 25mg 60 24 Capsule; White Opaque/White Opaque; ZA64/25 mg

Topiramate Tablets, USP | AB-Rated to Topamax® Tablets

68382-0138-14 25mg 60 24 Round; White to Off-White; ZD 16

68382-0138-05 25mg 500 12 Round; White to Off-White; ZD 16

68382-0139-14 50mg 60 24 Round; White to Off-White; ZD 15

68382-0139-05 50mg 500 12 Round; White to Off-White; ZD 15

68382-0140-14 100mg 60 24 Round; White to Off-White; ZD 14

68382-0140-05 100mg 500 12 Round; White to Off-White; ZD 14

68382-0141-14 200mg 60 24 Round; White to Off-White; ZD 13

68382-0141-05 200mg 500 12 Round; White to Off-White; ZD 13

Tramadol HCl Tablets, USP | AB-Rated to Ultram® Tablets

68382-0319-01 50mg 100 24 Round; White to Off-White; 319

68382-0319-10 50mg 1000 12 Round; White to Off-White; 319

Tramadol HCl/Acetaminophen Tablets, USP | AB-Rated to Ultracet® Tablets

68382-0334-01 37.5/325mg 100 24 Capsule-Shaped; White; 334

68382-0334-05 37.5/325mg 500 12 Capsule-Shaped; White; 334

| G E N E R I C P R O D U C T S

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

28Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

Page 31: ZYD Product Catalog Final 102219 - Zydususa

Trazodone HCl Tablets, USP | AB-Rated to Desyrel® Tablets

68382-0805-01 50mg 100 24 Round; White to Off-White; 805, Bisect

68382-0505-05 50mg 500 12 Round; White to Off-White; 805, Bisect

68382-0805-10 50mg 1000 12 Round; White to Off-White; 805, Bisect

68382-0806-01 100mg 100 24 Round; White to Off-White; 806, Bisect

68382-0806-05 100mg 500 12 Round; White to Off-White; 806, Bisect

68382-0806-10 100mg 1000 12 Round; White to Off-White; 806, Bisect

68382-0807-01 150mg 100 24 Oval; White to Off-White; 807, Bisect, Trisect notches/Trisect

68382-0807-05 150mg 500 12 Oval; White to Off-White; 807, Bisect, Trisect notches/Trisect

68382-0808-01 300mg 100 24 Oval; White to Off-White; 808, Bisect, Trisect notches/Trisect

Triamterene/Hydrochlorothiazide Tablets, USP | AB-Rated to Maxzide® Tablets

68382-0856-01 37.5/25mg 100 24 Round; Yellowish Green to Green; 856

68382-0856-05 37.5/25mg 500 12 Round; Yellowish Green to Green; 856

68382-0857-01 75/50mg 100 24 Round; Light Yellow to Yellow; 857

68382-0857-05 75/50mg 500 12 Round; Light Yellow to Yellow; 857

Trientine HCl Capsules, USP | AB-Rated to Syprine® Capsules

70710-1203-01 250mg 100 24 Capsule; Opaque Light Brown/Opaque White; 1203

Ursodiol Tablets, USP | AB-Rated to Urso® Forte Tablets

70710-1127-01 250mg 100 24 Oval; White to Off-White; 1127

70710-1128-01 500mg 100 24 Oval; White to Off-White; 1128

G E N E R I C P R O D U C T S |

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

29Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

Page 32: ZYD Product Catalog Final 102219 - Zydususa

Vardenafi l HCI Tablets | AB-Rated to Levitra® Tablets

70710-1068-03 2.5mg 30 24 Round; White to Off-White; 10/68

70710-1069-03 5mg 30 24 Round; Light Yellow; 10/69

70710-1070-03 10mg 30 24 Round; Light Yellow to Orange; 10/70

70710-1071-03 20mg 30 24 Round; Light Yellow to Orange; 10/71

Venlafaxine HCl Extended-Release Capsules, USP | AB-Rated to Effexor XR® Extended-Release Capsules

68382-0034-16 37.5mg 90 24 Capsule; Grey/White; ZA-35/37.5 mg

68382-0034-10 37.5mg 1000 12 Capsule; Grey/White; ZA-35/37.5 mg

68382-0035-16 75mg 90 24 Capsule; Peach/White; ZA-36/75 mg

68382-0035-10 75mg 1000 12 Capsule; Peach/White; ZA-36/75 mg

68382-0036-16 150mg 90 24 Capsule; Dark Orange/White; ZA-37/150 mg

68382-0036-10 150mg 1000 12 Capsule; Dark Orange/White; ZA-37/150 mg

Venlafaxine Tablets, USP | AB-Rated to Effexor® Tablets

68382-0018-01 25mg 100 24 Round; Peach; Bisect, ZC 64

68382-0019-01 37.5mg 100 24 Round; Peach; Bisect, ZC 65

68382-0020-01 50mg 100 24 Round; Peach; Bisect, ZC 66

68382-0021-01 75mg 100 24 Round; Peach; Bisect, ZC 67

68382-0101-01 100mg 100 24 Round; Peach; Bisect, ZC 68

Voriconazole Tablets | AB-Rated to Vfend® Tablets

68382-0735-06 50mg 30 24 Round; White to Off-White; 735

68382-0736-06 200mg 30 24 Oval; White to Off-White; 736

Zolmitriptan Orally Disintegrating Tablets | AB-Rated to Zomig-ZMT® Orally Disintegrating Tablets

68382-0715-86 2.5mg 1x6 Blister Pack 72 Round; White/Mottled White to Cream White; 715

68382-0717-82 5mg 1x3 Blister Pack 72 Round; White/Mottled White to Cream White; 717

| G E N E R I C P R O D U C T S

NDC STRENGTH SIZE CASE DESCRIPTION / IMPRINT CODE

30Product size and color may vary from the pictures in this catalog. All trademarks (™) and registered trademarks (®) are property of their respective companies.

z y d u s u s a . c o m

Page 33: ZYD Product Catalog Final 102219 - Zydususa

The following coding system is used for drug products that the FDA considers to be therapeutically equivalent to other pharmaceutically equivalent products. Approved drug products are considered to be therapeutic equivalents when they are pharmaceutical equivalents, have demonstrated bioequivalence, and can be expected to have the same clinical effect and safety profi le.1

A Codes - Products that are considered to be therapeutically equivalent to other pharmaceutically equivalent products

1. Orange Book Preface. Updated May 5th, 2019. https://www.fda.gov/Drugs/DevelopmentApprovalProcess/ucm079068.htm#TEC. Accessed February 22, 2019.

T H E R A P E U T I C E Q U I V A L E N C E C O D E S |

THERAPEUTIC EQUIVALENCE CODES

31

z y d u s u s a . c o m

AA Products in conventional dosage forms not presenting bioequivalence problems

AB Products meeting necessary bioequivalence requirements

AB1 Products meeting necessary bioequivalence requirements - used when there is more than one reference listed drug of the same strength under the same heading

AB2 Products meeting necessary bioequivalence requirements - used when there is more than one reference listed drug of the same strength under the same heading

AB3 Products meeting necessary bioequivalence requirements - used when there is more than one reference listed drug of the same strength under the same heading

AB4 Products meeting necessary bioequivalence requirements - used when there is more than one reference listed drug of the same strength under the same heading

AN Solutions and powders for aerosolization

AO Injectable oil solutions

AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions

AT Topical products

B Codes - Products requiring further FDA investigation and review to determine therapeutic equivalence

BC Extended-release dosage forms (capsules, injectables and tablets)

BD Active ingredients and dosage forms with documented bioequivalence problems

BE Delayed-release oral dosage forms

BN Products in aerosol-nebulizer drug delivery systems

BP Active ingredients and dosage forms with potential bioequivalence problems

BR Suppositories or enemas that deliver drugs for systemic absorption

BS Productshavingdrugstandarddeficiencies

BT Topical products with bioequivalence issues

BX Drugproductsforwhichthedataareinsufficienttodeterminetherapeuticequivalence

Page 34: ZYD Product Catalog Final 102219 - Zydususa

| T H E R A P E U T I C C A T E G O R I E S

Adrenals Budesonide Capsules (Enteric Coated) Entocort® EC Capusles

Alpha-Adrenergic Blocking Agents Doxazosin Tablets, USP Cardura® Tablets

Alpha-Adrenergic Blocking Agents Dutasteride/Tamsulosin HCl Capsules Jalyn® Capsules

Alpha-Adrenergic Blocking Agents Tamsulosin HCl Capsules, USP Flomax® Capsules

Ammonia Detoxicants Sodium Phenylacetate/Sodium Benzoate Injection Ammonul® Injection

Amphetamines Dextroamphetamine Saccharate, Amphetamine Aspartate, Adderall® Tablets Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets

Angiotensin II Receptor Antagonists Losartan Potassium Tablets, USP Cozaar® Tablets

Angiotensin II Receptor Antagonists Telmisartan Tablets, USP Micardis® Tablets

Anthelmintics Albendazole Tablets, USP Albenza® Tablets

Antiarrhythmic Agents Amiodarone HCl Tablets Cordarone® Tablets

Antibacterials; Tetracyclines Doxycycline Hyclate Injection, USP Doxy 100® Injection

Antibacterials; Tetracyclines Doxycycline Monohydrate Capsules, USP Monodox® Capsules

Antibacterials; Tetracyclines Doxycycline Monohydrate Tablets, USP Adoxa® Tablets

Antibacterials; Tetracyclines Minocycline HCl Capsules, USP Minocin® Capsules

Anticonvulsants ClobazamTablets Onfi®Tablets

Anticonvulsants Divalproex Sodium Capsules (Sprinkle), USP Depakote® Sprinkle Capsules

Anticonvulsants Gabapentin Tablets, USP Neurontin® Tablets

Anticonvulsants Lamotrigine Tablets, USP Lamictal® Tablets

Anticonvulsants Topiramate Capsules (Sprinkle), USP Topamax® Sprinkle Capsules

Anticonvulsants Topiramate Tablets, USP Topamax® Tablets

Antidepressants Amitriptyline HCl Tablets, USP Elavil® Tablets

Antidepressants Bupropion HCl Extended-Release Tablets, USP Wellbutrin® XL Extended-Release Tablets

Antidepressants Clomipramine HCl Capsules, USP Anafranil® Capsules

Antidepressants Duloxetine Delayed-Release Capsules, USP Cymbalta® Delayed-Release Capsules

Antidepressants Paroxetine Tablets, USP Paxil® Tablets

Antidepressants Trazodone HCl Tablets, USP Desyrel® Tablets

Antidepressants Venlafaxine HCl Extended-Release Capsules, USP Effexor XR® Extended-Release Capsules

Antidepressants Venlafaxine HCl Tablets, USP Effexor® Tablets

Antidiabetic Agents Metformin HCl Tablets, USP Glucophage® Tablets

Antidiabetics Glipizide Extended-Release Tablets Glucotrol® XL Extended-Release Tablets

Therapeutic Category Generic Name Brand Name

Please see full prescribing information for FDA-approved indications and dosage. Therapeutic Categories are not to be used as a replacement for reviewing FDA-approved prescribing information and are aligned to the American Hospital Formulary Service (AHFS) Therapeutic Classification System maintained by the American Society of Health-System Pharmacists (ASHP).

32

z y d u s u s a . c o m

Page 35: ZYD Product Catalog Final 102219 - Zydususa

Antidiabetics Glipizide/Metformin HCl Tablets, USP Metaglip® Tablets

Antidiabetics Nateglinide Tablets, USP Starlix® Tablets

Antidotes Fomepizole Injection Antizol® Injection

Antifungals FluconazoleTablets,USP Diflucan®Tablets

Antifungals Voriconazole Tablets Vfend® Tablets

Antigout Agents Allopurinol Tablets, USP Zyloprim® Tablets

Anti-inflammatoryAgents ClobetasolPropionateOintment,USP Temovate®Ointment

Anti-inflammatoryAgents ClobetasolPropionateSpray Clobex®Spray

Anti-inflammatoryAgents ClobetasolPropionateCream,USP Temovate®Cream

Anti-inflammatoryAgents MesalamineDelayed-ReleaseTablets Lialda®Delayed-ReleaseTablets

Anti-inflammatoryAgents MesalamineDelayed-ReleaseTablets,USP Asacol®HDDelayed-ReleaseTablets

Antilipemic Agents Atorvastatin Calcium Tablets, USP Lipitor® Tablets

Antilipemic Agents Cholestyramine Light Powder for Suspension Questran® Light Powder for Suspension

Antilipemic Agents Cholestyramine Powder for Suspension, USP Questran® Powder for Suspension

AntilipemicAgents FenofibrateTablets TriCor®Tablets

Antilipemic Agents Pravastatin Sodium Tablets, USP Pravachol® Tablets

Antimalarials Carmustine Injection, USP BiCNU® Injection

Antimigraine Agents Eletriptan HBr Tablets Relpax® Tablets

Antimigraine Agents Zolmitriptan Orally Disintegrating Tablets Zomig-ZMT® Orally Disintegrating Tablets

Antimuscarinics Oxybutynin Chloride Extended-Release Tablets Ditropan XL® Extended-Release Tablets

Antineoplastic Agents Arsenic Trioxide Injection Trisenox® Injection

Antineoplastic Agents Methotrexate Tablets, USP Rheumatrex® Tablets

Antineoplastic Agents Tamoxifen Citrate Tablets, USP Nolvadex® Tablets

Antineoplastic Agents Temozolomide Capsules Temodar® Capsules

Antiparkinson Agents; Antivirals Amantadine HCl Capsules, USP Symmetrel® Capsules

Antiparkinsonian Agents Benztropine Mesylate Injection Cogentin® Injection

Antiparkinsonian Agents Bromocriptine Mesylate Capsules, USP Parlodel® Capsules

Antipsychotic Agents Haloperidol Tablets, USP Haloperidol Tablets, USP

Antipsychotic Agents Risperidone Tablets, USP Risperdal® Tablets

Antitussives Benzonatate Capsules, USP Tessalon® Perles

Therapeutic Category Generic Name Brand Name

Please see full prescribing information for FDA-approved indications and dosage. Therapeutic Categories are not to be used as a replacement for reviewing FDA-approved prescribing information and are aligned to the American Hospital Formulary Service (AHFS) Therapeutic Classification System maintained by the American Society of Health-System Pharmacists (ASHP).

T H E R A P E U T I C C A T E G O R I E S | 33

z y d u s u s a . c o m

Page 36: ZYD Product Catalog Final 102219 - Zydususa

Please see full prescribing information for FDA-approved indications and dosage. Therapeutic Categories are not to be used as a replacement for reviewing FDA-approved prescribing information and are aligned to the American Hospital Formulary Service (AHFS) Therapeutic Classification System maintained by the American Society of Health-System Pharmacists (ASHP).

| T H E R A P E U T I C C A T E G O R I E S

Anti-inflammatoryAgents BetamethasoneDipropionateCream,USP Diprosone®Cream

Anti-inflammatoryAgents DesoximetasoneOintment,USP Topicort®Ointment

Antiulcer Agents/Acid Suppressants Methylprednisolone Tablets, USP Medrol® Tablets

Antivirals Acyclovir Ointment, USP Zovirax® Ointment

Antivirals Acyclovir Tablets, USP Zovirax® Tablets

Antivirals Entecavir Tablets Baraclude® Tablets

Antivirals OseltamivirPhosphateCapsules,USP Tamiflu®Capsules

Antivirals OseltamivirPhosphateforSuspension Tamiflu®forSuspension

Antivirals Ribavirin Capsules, USP Rebetol® Capsules

Antivirals Ribavirin for Inhalation Solution, USP Virazole® for Inhalation Solution

Antivirals Ribavirin Tablets Copegus® Tablets

Anxiolytics, Sedatives, and Hypnotics Buspirone HCl Tablets, USP BuSpar® Tablets

Anxiolytics, Sedatives, and Hypnotics Ramelteon Tablets Rozerem® Tablets

Beta-Adrenergic Blocking Agents Atenolol Tablets, USP Tenormin® Tablets

Beta-Adrenergic Blocking Agents Carvedilol Tablets, USP Coreg® Tablets

Beta-Adrenergic Blocking Agents Labetalol HCl Tablets, USP Normodyne® Tablets

Beta-Adrenergic Blocking Agents Metoprolol Succinate Extended-Release Tablets, USP Toprol-XL® Extended-Release Tablets

Beta-Adrenergic Blocking Agents Nadolol Tablets, USP Corgard® Tablets

Beta-Adrenergic Blocking Agents Spironolactone Tablets, USP Aldactone® Tablets

Calcium-Channel Blocking Agents Diltiazem HCl Extended-Release Capsules, USP Cardizem® CD Extended-Release Capsules

Cardiovascular Agents Atenolol/Chlorthalidone Tablets, USP Tenoretic® Tablets

Central Nervous System Agents Acamprosate Calcium Delayed-Release Tablets Campral® Delayed-Release Tablets

CentrallyActingSkeletal TizanidineHClCapsules Zanaflex®Capsules Muscle Relaxants

Cholelitholytic Agents Ursodiol Tablets, USP Urso® Forte Tablets

Cholesterol Absorption Inhibitors Ezetimibe Tablets, USP Zetia® Tablets

Dihydropyridines Amlodipine Besylate Tablets, USP Norvasc® Tablets

Disease-modifyingAntirheumatic LeflunomideTablets,USP Arava®Tablets

Diuretics Bumetanide Tablets, USP Bumex® Tablets

Diuretics Ethacrynate Sodium for Injection, USP Edecrin® Injection

Diuretics Triamterene/Hydrochlorothiazide Tablets, USP Maxzide® Tablets

Estrogens and Estrogen Anastrozole Tablets, USP Arimidex® Tablets Agonists-Antagonists

Estrogens and Estrogen Exemestane Tablets Aromasin® Tablets Agonists-Antagonists

First Generation Antihistamines Cyproheptadine HCl Tablets, USP Periactin® Tablets

First Generation Antihistamines Promethazine HCl Tablets, USP Phenergan® Tablets

Therapeutic Category Generic Name Brand Name

34

z y d u s u s a . c o m

Page 37: ZYD Product Catalog Final 102219 - Zydususa

Please see full prescribing information for FDA-approved indications and dosage. Therapeutic Categories are not to be used as a replacement for reviewing FDA-approved prescribing information and are aligned to the American Hospital Formulary Service (AHFS) Therapeutic Classification System maintained by the American Society of Health-System Pharmacists (ASHP).

T H E R A P E U T I C C A T E G O R I E S |

Therapeutic Category Generic Name Brand Name

GABA-derivative Skeletal Baclofen Tablets, USP Lioresal® Tablets Muscle Relaxants

HCV Antivirals Hydroxychloroquine Sulfate Tablets, USP Plaquenil® Tablets

Heavy Metal Antagonists Trientine HCl Capsules, USP Syprine® Capsules

Histamine H2-Antagonists Ranitidine Injection, USP Zantac® Injection

Immunosuppressive Agents Azathioprine Tablets, USP Imuran® Tablets

Immunosuppressive Agents Sirolimus Tablets Rapamune® Tablets

Macrolides Azithromycin Oral Suspension, USP Zithromax® Oral Suspension

Neuromuscular Blocking Agents Succinylcholine Chloride Injection, USP Quelicin® Injection

NonsteroidalAnti-inflammatoryAgents EtodolacExtended-ReleaseTablets,USP LodineXL®Extended-ReleaseTablets

NonsteroidalAnti-inflammatoryAgents IndomethacinInjection,USP Indocin®Injection

NonsteroidalAnti-inflammatoryAgents MeloxicamTablets,USP Mobic®Tablets

Opiate Agonists Tramadol HCl Tablets, USP Ultram® Tablets

Opiate Agonists Tramadol HCl/Acetaminophen Tablets, USP Ultracet® Tablets

Parasympathomimetic Pyridostigmine Bromide Tablets, USP Mestinon® Tablets (Cholinergic) Agents

Parasympathomimetic Rivastigmine Transdermal Patch Exelon® Transdermal Patch (Cholinergic) Agents

Parathyroid and Antiparathyroid Agents Desmopressin Acetate Nasal Spray DDAVP® Nasal Spray

PhosphodiesteraseType5Inhibitors VardenafilTablets Levitra®Tablets

Proton-pump Inhibitors Esomeprazole Magnesium Nexium® Delayed-Release Capsules Delayed-Release Capsules, USP

Proton-pump Inhibitors Lansoprazole Delayed-Release Capsules, USP Prevacid® Delayed-Release Capsules

Proton-pump Inhibitors Lansoprazole Delayed-Release Prevacid® SoluTab Delayed-Release Orally-Disintegrating Tablets Orally-Disintegrating Tablets

Proton-pump Inhibitors Omeprazole Delayed-Release Tablets, USP Prilosec® Delayed-Release Capsules

Proton-pump Inhibitors Omeprazole/Sodium Bicarbonate Capsules Zegerid® Capsules

Renin-Angiotensin-Aldosterone Ramipril Capsules, USP Altace® Capsules System Inhibitors

Replacement Preparations Potassium Chloride Extended-Release Tablets, USP K-Tab® Extended-Release Tablets

Replacement Preparations Potassium Citrate Extended-Release Tablets, USP Urocit-K® Extended-Release Tablets

Skin and Mucous Membrane Agents Nitroglycerin Transdermal System Nitroglycerin Transdermal System (AB2 rating)

Urinary Anti-infectives Nitrofurantoin Capsules, USP (Macrocrystals) Macrodantin® Capsules

Vasodilating Agents Ambrisentan Tablets Letairis® Tablets

Vasodilating Agents Bosentan Tablets Tracleer® Tablets

Vasodilating Agents Isosorbide Mononitrate ER Tablets Imdur® Extended-Release Tablets

VasodilatingAgents TadalafilTablets,USP Cialis®Tablets

Vitamin D Paricalcitol Capsules Zemplar® Capsules

Vitamin K Phytonadione Tablets, USP Mephyton® Tablets

35

z y d u s u s a . c o m

Page 38: ZYD Product Catalog Final 102219 - Zydususa

| B R A N D T O G E N E R I C G U I D E

Adderall® Tablets Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets

Adoxa® Tablets Doxycycline Monohydrate Tablets, USP

Albenza® Tablets Albendazole Tablets, USP

Aldactone® Tablets Spironolactone Tablets, USP

Altace® Capsules Ramipril Capsules, USP

Ammonul® Injection Sodium Phenylacetate/Sodium Benzoate Injection

Anafranil® Capsules Clomipramine HCl Capsules, USP

Antizol® Injection Fomepizole Injection

Arava®Tablets LeflunomideTablets,USP

Arimidex® Tablets Anastrozole Tablets, USP

Aromasin® Tablets Exemestane Tablets

Asacol® HD Delayed-Release Tablets Mesalamine Delayed-Release Tablets, USP

Baraclude® Tablets Entecavir Tablets

BiCNU® Injection Carmustine Injection, USP

Bumex® Tablets Bumetanide Tablets, USP

BuSpar® Tablets Buspirone HCl Tablets, USP

Campral® Delayed-Release Tablets Acamprosate Calcium Delayed-Release Tablets

Cardizem® CD Extended-Release Capsules Diltiazem HCl Extended-Release Capsules, USP

Cardura® Tablets Doxazosin Tablets, USP

Cialis®Tablets TadalafilTablets,USP

Clobex® Spray Clobetasol Propionate Spray

Cogentin® Injection Benztropine Mesylate Injection

Copegus® Tablets Ribavirin Tablets

Cordarone® Tablets Amiodarone HCl Tablets

Coreg® Tablets Carvedilol Tablets, USP

Corgard® Tablets Nadolol Tablets, USP

Cozaar® Tablets Losartan Potassium Tablets, USP

Cymbalta® Delayed-Release Capsules Duloxetine Delayed-Release Capsules, USP

DDAVP® Nasal Spray Desmopressin Acetate Nasal Spray

Depakote® Sprinkle Capsules Divalproex Sodium Capsules (Sprinkle), USP

Desyrel® Tablets Trazodone HCl Tablets, USP

Diflucan®Tablets FluconazoleTablets,USP

Brand Name Generic Name

36

BRAND TO GENERIC GUIDE

z y d u s u s a . c o m

Page 39: ZYD Product Catalog Final 102219 - Zydususa

B R A N D T O G E N E R I C G U I D E |

Diprosone® Cream Betamethasone Dipropionate Cream, USP

Ditropan XL® Extended-Release Tablets Oxybutynin Chloride Extended-Release Tablets

Doxy 100® Injection Doxycycline Hyclate Injection, USP

Edecrin® Injection Ethacrynate Sodium for Injection, USP

Effexor XR® Extended-Release Capsules Venlafaxine HCl Extended-Release Capsules, USP

Effexor® Tablets Venlafaxine HCl Tablets, USP

Elavil® Tablets Amitriptyline HCl Tablets, USP

Entocort® EC Capusles Budesonide Capsules (Enteric Coated)

Exelon® Transdermal Patch Rivastigmine Transdermal Patch

Flomax® Capsules Tamsulosin HCl Capsules, USP

Glucophage® Tablets Metformin HCl Tablets, USP

Glucotrol® XL Extended-Release Tablets Glipizide Extended-Release Tablets

Haloperidol Tablets, USP Haloperidol Tablets, USP

Imdur® Extended-Release Tablets Isosorbide Mononitrate ER Tablets

Imuran® Tablets Azathioprine Tablets, USP

Indocin® Injection Indomethacin Injection, USP

Jalyn® Capsules Dutasteride/Tamsulosin HCl Capsules

K-Tab® Extended-Release Tablets Potassium Chloride Extended-Release Tablets, USP

Lamictal® Tablets Lamotrigine Tablets, USP

Letairis® Tablets Ambrisentan Tablets

Levitra®Tablets VardenafilTablets

Lialda® Delayed-Release Tablets Mesalamine Delayed-Release Tablets

Lioresal® Tablets Baclofen Tablets, USP

Lipitor® Tablets Atorvastatin Calcium Tablets, USP

Lodine XL® Extended-Release Tablets Etodolac Extended-Release Tablets, USP

Macrodantin® Capsules Nitrofurantoin Capsules, USP (Macrocrystals)

Maxzide® Tablets Triamterene/Hydrochlorothiazide Tablets, USP

Medrol® Tablets Methylprednisolone Tablets, USP

Mephyton® Tablets Phytonadione Tablets, USP

Mestinon® Tablets Pyridostigmine Bromide Tablets, USP

Metaglip® Tablets Glipizide/Metformin HCl Tablets, USP

Micardis® Tablets Telmisartan Tablets, USP

Minocin® Capsules Minocycline HCl Capsules, USP

Brand Name Generic Name

37

z y d u s u s a . c o m

Page 40: ZYD Product Catalog Final 102219 - Zydususa

| B R A N D T O G E N E R I C G U I D E

Mobic® Tablets Meloxicam Tablets, USP

Monodox® Capsules Doxycycline Monohydrate Capsules, USP

Neurontin® Tablets Gabapentin Tablets, USP

Nexium® Delayed-Release Capsules Esomeprazole Magnesium Delayed-Release Capsules, USP

Nitroglycerin Transdermal System (AB2 rating) Nitroglycerin Transdermal System

Nolvadex® Tablets Tamoxifen Citrate Tablets, USP

Normodyne® Tablets Labetalol HCl Tablets, USP

Norvasc® Tablets Amlodipine Besylate Tablets, USP

Onfi®Tablets ClobazamTablets

Parlodel® Capsules Bromocriptine Mesylate Capsules, USP

Paxil® Tablets Paroxetine Tablets, USP

Periactin® Tablets Cyproheptadine HCl Tablets, USP

Phenergan® Tablets Promethazine HCl Tablets, USP

Plaquenil® Tablets Hydroxychloroquine Sulfate Tablets, USP

Pravachol® Tablets Pravastatin Sodium Tablets, USP

Prevacid® Delayed-Release Capsules Lansoprazole Delayed-Release Capsules, USP

Prevacid® SoluTab Delayed-Release Lansoprazole Delayed-Release Orally-Disintegrating Tablets Orally-Disintegrating Tablets

Prilosec® Delayed-Release Capsules Omeprazole Delayed-Release Tablets, USP

Quelicin® Injection Succinylcholine Chloride Injection, USP

Questran® Light Powder for Suspension Cholestyramine Light Powder for Suspension

Questran® Powder for Suspension Cholestyramine Powder for Suspension, USP

Rapamune® Tablets Sirolimus Tablets

Rebetol® Capsules Ribavirin Capsules, USP

Relpax® Tablets Eletriptan HBr Tablets

Rheumatrex® Tablets Methotrexate Tablets, USP

Risperdal® Tablets Risperidone Tablets, USP

Roxicodone® Tablets Oxycodone HCl Tablets, USP

Rozerem® Tablets Ramelteon Tablets

Starlix® Tablets Nateglinide Tablets, USP

Symmetrel® Capsules Amantadine HCl Capsules, USP

Syprine® Capsules Trientine HCl Capsules, USP

Tamiflu®Capsules OseltamivirPhosphateCapsules,USP

Tamiflu®forSuspension OseltamivirPhosphateforSuspension

Brand Name Generic Name

38

BRAND TO GENERIC GUIDE

z y d u s u s a . c o m

Page 41: ZYD Product Catalog Final 102219 - Zydususa

B R A N D T O G E N E R I C G U I D E |

Temodar® Capsules Temozolomide Capsules

Temovate® Cream Clobetasol Propionate Cream, USP

Temovate® Ointment Clobetasol Propionate Ointment, USP

Tenoretic® Tablets Atenolol/Chlorthalidone Tablets, USP

Tenormin® Tablets Atenolol Tablets, USP

Tessalon® Perles Benzonatate Capsules, USP

Topamax® Sprinkle Capsules Topiramate Capsules (Sprinkle), USP

Topamax® Tablets Topiramate Tablets, USP

Topicort® Ointment Desoximetasone Ointment, USP

Toprol-XL® Extended-Release Tablets Metoprolol Succinate Extended-Release Tablets, USP

Tracleer® Tablets Bosentan Tablets

TriCor®Tablets FenofibrateTablets

Trisenox® Injection Arsenic Trioxide Injection

Ultracet® Tablets Tramadol HCl/Acetaminophen Tablets, USP

Ultram® Tablets Tramadol HCl Tablets, USP

Urocit-K® Extended-Release Tablets Potassium Citrate Extended-Release Tablets, USP

Urso® Forte Tablets Ursodiol Tablets, USP

Vfend® Tablets Voriconazole Tablets

Virazole® for Inhalation Solution Ribavirin for Inhalation Solution, USP

Wellbutrin® XL Extended-Release Tablets Bupropion HCl Extended-Release Tablets, USP

Zanaflex®Capsules TizanidineHClCapsules

Zantac® Injection Ranitidine Injection, USP

Zegerid® Capsules Omeprazole/Sodium Bicarbonate Capsules

Zemplar® Capsules Paricalcitol Capsules

Zetia® Tablets Ezetimibe Tablets, USP

Zithromax® Oral Suspension Azithromycin Oral Suspension, USP

Zomig-ZMT® Orally Disintegrating Tablets Zolmitriptan Orally Disintegrating Tablets

Zovirax® Ointment Acyclovir Ointment, USP

Zovirax® Tablets Acyclovir Tablets, USP

Zyloprim® Tablets Allopurinol Tablets, USP

Brand Name Generic Name

39

z y d u s u s a . c o m

Page 42: ZYD Product Catalog Final 102219 - Zydususa

Customer Service:Zydus Pharmaceuticals (USA) Inc.73 Route 31 NorthPennington, NJ 08534

Hours of Operation:9:00 AM - 5:00 PM EST, Monday-Friday

Phone:877-ZYDUS RX, Prompt 1 (877-993-8779, Prompt 1)

Fax:877-993-9055

Remit To:Zydus Pharmaceuticals (USA) Inc.73 Route 31 NorthPennington, NJ 08534

Minimum Order Requirements:The minimum order for each SKU is one case pack (usually a quantity of 12 or 24). The total order must exceed $1,000.00.All orders will be shipped on a prepaid basis utilizing the method of transportation selected by Zydus Pharmaceuticals. In cases where customer requests are expedited, more expensive, or special handling of an order, Zydus Pharmaceuticals reserves the right to charge the customer for these expenses.

ORDERING INFORMATION

| O R D E R I N G I N F O R M A T I O N40

z y d u s u s a . c o m

Page 43: ZYD Product Catalog Final 102219 - Zydususa

ZYDUS PHARMACEUTICALS (USA) INC. RETURN GOODS POLICYCustomer Service:This return goods policy applies to all ZyGeneric (68382), (70710) and Nesher (51477) labeled pharmaceutical products. All ZyGeneric and Nesher product returns must be sent prepaid to our designated return goods processor to the following address: Inmar- South Dock, 4332 Empire Road, Fort Worth, TX 76155. Zydus does not pay fees such as processing charges for returning any product other than recalled product. For customers using other return companies for processing and destruction Zydus will not assume responsibility for charges incurred.

Request for Return Authorizations (box labels) can be made by any of the below methods:1. Accessing the Inmar website at https://clsnetlink.com (you will need to upload a PDF copy of your

debit memo)2. E-mail your debit memo to [email protected]. Be sure to include NDC#, lot# and expiration

dates assigned to each item.3. Fax your debit memo to Inmar at 817-868-5343

Returnable Items (For Reimbursement):• Products within six (6) months of expiration date and up to 12 months after the expiration date stated on

the package. Products must be in sealed, full, unopened, original Zydus or Nesher containers.• Products received in error or damaged in shipping to consignee (accompanied by a signed bill of lading

noting such damage) if reported to Zydus customer service within 5 days of receipt and returned within 30 days

• Prior written approval is required for all return of all overstocked product with greater than 12 months expiration dating. This merchandise will be subject to a 15% restocking fee.

• A DEA Form 222 is required in order to return C-II controlled substances. Please send DEA Form 222 requests to: Fax # (817) 868-5342 or E-mail: [email protected]

Returnable Items (No Credit):• Products returned without an approved Product Return Form• Products sold on a non-returnable basis, professional sample, or free goods• Partial or open bottles, except where required by law•Productwhichhasbeenrepackaged,productpurchasedthroughabankruptcysale,firesale,distress

merchandise, or product not in original container are not eligible for credit. Zydus will not credit for productdamagedduetoinsurablecausessuchasfire,floodsorearthquake.

• Products with broken seals, opened, coded, dated, damaged or missing label, or soiled packages• Products damaged at customer’s warehouse or store, or not stored under proper conditions• Products with greater than six months expiration dating or are greater than 12 months past the

expiration date• Private label products• Return of over stocked product without prior written approval of Zydus• Merchandise distributed contrary to federal, state or local laws• Product not purchased from either Zydus or the customer’s authorized distributor / wholesaler

R E T U R N G O O D S P O L I C Y | 41

z y d u s u s a . c o m

Page 44: ZYD Product Catalog Final 102219 - Zydususa

RETURN GOODS POLICY (cont)

Valuation of Returns:• Direct buying customers will be issued a credit by Zydus. This credit will be issued at the lowest

of either original invoice price or the prevailing contract price on the date the goods are returned to Zydus.

• Non-Direct customers will receive credit directly from Inmar. If no contract exists, the credit will be issued based upon the lower of the current Zydus standard market price at the time the returned merchandise is received by Inmar OR the original Zydus contract price at point of purchase from the wholesaler.

Transportation Charges:• Prepaid by customer, unless shipped in error by Zydus• Returned product shipped collect will be refused

Miscellaneous:• Representatives cannot authorize return of in date product or pick up merchandise•Returnedproductswillbepromptlyevaluatedandcreditwillreflecteligibilityand/or

ineligibility. All products returned, whether eligible for credit or not, become property of Zydus.Allproductsarereturnedwiththeunderstandingthattheyaresubjecttofinalreviewand evaluation by Zydus, and will be processed in accordance with the most recent return policy in effect at the time of the return.

• Wholesalers are not authorized to accept returns of Zydus products except in the case of mis-shipments or other ordering errors

• Return chargebacks will be paid on original invoice date• Zydus reserves the right to amend this policy at any time• Claim merchandise-even exchange or credit will be allowed for loss or damage evident atdeliverytimeifnotedonthecarrier’deliveryreceiptandreportedtouswithinfivedays.Concealed loss or damage must be inspected by carrier within 15 days after delivery and carrier’s inspection report must be forwarded to Zydus USA.

• Zydus USA policy strictly prohibits any sales representative or any other employee from giving samples or stock packages to any customer to replace merchandise. All returns must be made according to this return goods policy.

| R E T U R N G O O D S P O L I C Y42

z y d u s u s a . c o m

Page 45: ZYD Product Catalog Final 102219 - Zydususa

Address Zydus Pharmaceuticals (USA) Inc. 73 Route 31 North Pennington, NJ 08534

Telephone: 609-730-1900 Fax: 609-730-1998 Website: www.zydususa.com

Customer Service Telephone: 877-993-8779, Prompt 1 Fax: 877-993-9055 Email: [email protected]

Medical Affairs Telephone: 877-993-8779, Prompt 2 Fax: 678-581-4401 Email: [email protected]

Returns Inmar: 800-967-5952

CONTACT INFORMATION

C O N T A C T I N F O R M A T I O N | 43

z y d u s u s a . c o m

Page 46: ZYD Product Catalog Final 102219 - Zydususa

www.zydususa.com

Zydus Pharmaceuticals (USA) Inc.73 Route 31 N.Pennington, NJ 08534(877) ZYDUS RX or (877) 993-8779